April 29, 2016

April 29, 2016

FDA Approves Second Biosimilar Since Releasing Labeling Guidance, Despite Patent Protection, Safety Concerns
Cancer Therapy Advisor – April 28
“The concept of having new versions of older drugs is a great one,” Howard McLeod, PharmD, FCCP, medical director of the DeBartolo Family Personalized Medical Institute at Moffitt Cancer Center in Tampa, FL, told Cancer Therapy Advisor. “What's difficult is knowing whether what's similar is truly equal.”

Going the distance: Miles for Moffitt helps cancer research move forward
Tampa Bay Times – April 28
Suzanne Oles wasn't well enough to join the crowd at last year's Miles for Moffitt fundraiser. She was in the middle of chemotherapy treatment for lung cancer.

What does it mean to have ‘dense’ breasts?
SELF Magazine – April 27
Brian Czerniecki, M.D., Ph.D., chair of the Moffitt Cancer Center department of breast oncology tells SELF that most physicians still don’t know what having dense breasts means for a woman’s health. However, they do know that women with dense breasts have an increased risk of breast cancer, and that mammograms have difficulty detecting lumps or cancerous growths in women with dense breasts. 

Imaging tumour habitats – life at the edge
eCancer – April 26
Robert Gillies, Moffitt Cancer Center, Tampa, USA talks to ecancertv at AACR 2016 about novel imaging techniques in tumour habitats. Considering the stalling durable response rate of many targeted-therapy patients due to tumour evolution, Dr Gillies discusses the value of multiple imaging techniques to determining tumour habitat and response potential.

Less invasive mastectomy touted
Standard-Times – April 26
The study's senior author is Shawna Willey, M.D., of Georgetown University. The co-authors are Richard Gray, M.D., and Sarah McLaughlin, M.D., of Mayo Clinic; Anne Peled, M.D., of the University of California San Francisco; Rachel Greenup, M.D., of Duke University; John Kiluk, M.D., of Moffitt Cancer Center; Virgilio Sacchini, M.D., of Memorial Sloan Kettering; and Julia Tchou, M.D., Ph.D., of the University of Pennsylvania.

Groundbreaking for new cancer research/treatment facility
WPMI NBC – April 26
Created in 2001, the Mitchell Cancer Institute was modeled after the H. Lee Moffitt Cancer & Research Institute in Tampa, Fla. MCI employs about 300 people, including health-care providers, cancer researchers and staff, and is the only cancer treatment and research institute located on the Gulf Coast corridor.

Priority Health
Bay News 9 – April 26
Breakthrough Treatment - for prostate cancer, and it's happening right here in the bay area  at Moffitt Cancer Center. There's a new test called "decipher." it diagnoses different forms of prostate cancer, and allows doctors to create individual treatment plans for patients. 

Innovation in Car T-Cell design may help improve safety, efficacy
Healio – April 25
Marco L. Davila, MD, PhD, medical oncologist at Moffitt Cancer Center, reacts to an abstract presented at the American Association for Cancer Research Annual Meeting that described a new innovation in chimeric antigen receptor T-cell therapy.

Sunitinib and Sorafenib May Not Prevent Recurrence Following Resection in High-risk, Non-metastatic RCC
Cancer Therapy Advisor – April 25
Philippe Spiess, MD, who is a genitourinary oncologist at Moffitt Cancer Center and an associate professor of oncology and urology at the University of South Florida Morsani College of Medicine in Tampa, said the results of the present study raised the question: “what, if anything, can be offered to patients exhibiting adverse pathological features following kidney cancer surgical resection in the absence of suspected metastatic disease?”

Many Woman With Breast Cancer Are Choosing Double Mastectomies Unnecessarily
Self Magazine – April 22
“There’s a common misconception that having a double mastectomy is the way to go, and you’re going to get a better survival rate,” Brian Czerniecki, M.D., Ph.D., chair of the the Moffitt Cancer Center department of breast oncology, tells SELF. “That’s not exactly true, and a lot of people overestimate their risk of getting cancer in the other breast.”

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.